Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Scope & Guideline
Pioneering insights for a brighter future in Alzheimer's research.
Introduction
Aims and Scopes
- Multimodal Biomarkers and Diagnostic Techniques:
Research involving cerebrospinal fluid (CSF), blood-based biomarkers, neuroimaging, and genetic factors to improve the diagnosis and understanding of Alzheimer's disease pathology. - Cognitive Assessment and Monitoring Tools:
Development and validation of cognitive assessment tools, including digital and remote testing methods, aimed at early detection and monitoring of cognitive decline. - Neuropsychiatric Symptoms and Behavioral Factors:
Exploration of the relationship between neuropsychiatric symptoms, behavioral changes, and cognitive impairment in dementia patients. - Lifestyle and Environmental Influences:
Studies examining the impact of lifestyle factors, such as physical activity, diet, and socioeconomic status, on cognitive health and dementia risk. - Health Disparities and Ethnic Variability:
Research addressing the differences in dementia prevalence, risk factors, and outcomes across diverse populations, focusing on health equity and access to care. - Technological Innovations in Research:
Utilization of machine learning, artificial intelligence, and digital health technologies for improving diagnostic precision and understanding of cognitive decline.
Trending and Emerging
- AI and Machine Learning Applications:
There is a rising trend in utilizing AI and machine learning techniques to analyze cognitive decline, identify biomarkers, and improve diagnostic accuracy. - Integration of Lifestyle Factors:
An increasing number of studies are focusing on how lifestyle factors, such as nutrition, physical activity, and social engagement, influence cognitive health and dementia risk. - Biomarker Discovery and Validation:
Research on novel biomarkers, particularly blood-based and neuroimaging biomarkers, is gaining traction as a means to enhance early detection and monitoring of Alzheimer's disease. - Cultural and Social Determinants of Health:
A growing interest in understanding how cultural and social determinants influence dementia prevalence and outcomes, particularly in diverse populations, is evident in recent publications. - Digital Health Interventions:
Emerging interest in digital tools and remote monitoring technologies for assessing cognitive function and delivering interventions, especially in the context of the COVID-19 pandemic. - Comorbidity and Multimorbidity Research:
Research exploring the interactions between Alzheimer's disease and other chronic conditions, highlighting the complexity of patient care and the need for integrated health strategies.
Declining or Waning
- Traditional Cognitive Assessment Methods:
There has been a noticeable decrease in studies solely focused on conventional cognitive assessments, as the field moves towards more innovative and diverse methods of evaluation. - Single-Factor Risk Assessments:
Research that examines isolated risk factors for dementia without considering the multimodal interactions has become less common, with a growing emphasis on comprehensive, integrative approaches. - Aging without Cognitive Decline Focus:
Studies that exclusively investigate aging without a direct connection to cognitive decline or dementia have diminished, as the focus shifts towards understanding the cognitive trajectories related to aging. - Generalized Dementia Studies:
Research that does not differentiate between types of dementia (e.g., Alzheimer’s versus Lewy body dementia) is less frequent, as there is a growing recognition of the need for subtype-specific investigations.
Similar Journals
BEHAVIOURAL NEUROLOGY
Exploring the Mind: Where Neurology Meets BehaviorBEHAVIOURAL NEUROLOGY is a distinguished open-access journal published by Hindawi Ltd, dedicated to advancing the field of neurology and neuropsychology since its inception in 1988. With ISSN: 0953-4180 and E-ISSN: 1875-8584, this journal provides a platform for innovative research and interdisciplinary studies that explore the intricate connections between behavior and neurological processes. Housed in the Netherlands, BEHAVIOURAL NEUROLOGY enjoys a commendable reputation, boasting impressive quartile rankings of Q2 in various medical and psychological categories, reflecting its significant contribution to the literature with a focus on clinical neurology and physiological psychology. The journal's rigorous peer-review process ensures that published works meet high academic standards, making it an essential resource for researchers, clinicians, and students seeking to deepen their understanding of neurological disorders and cognitive function. As of 2023, it ranks in the 80th percentile in neuropsychology, further underscoring its impact and relevance in the scientific community. For those interested in accessible knowledge, BEHAVIOURAL NEUROLOGY's commitment to open access facilitates the dissemination of groundbreaking research, allowing a wider audience to engage with critical advancements in the field.
NEUROBIOLOGY OF AGING
Transforming Understanding of Aging Through NeurobiologyNEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.
Dementia and Geriatric Cognitive Disorders Extra
Exploring innovative research in geriatric neuroscience.Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.
BRAIN
Transforming Medical Research through Rigorous Peer ReviewBRAIN, published by Oxford University Press, stands as a preeminent journal in the realms of neurology and medicine, with a formidable impact factor reflecting its rigorous peer-reviewed standards and significant contributions to the field. With its ISSN 0006-8950 and E-ISSN 1460-2156, this esteemed publication spans over a century of exceptional research, converging from its historical roots in 1878 to current groundbreaking studies. BRAIN boasts a distinguished rank of #8 out of 400 in the Scopus category of Neurology (Clinical), placing it in the 98th percentile of institutions, indicative of its influence and reach. Operating under the Q1 category in both Medicine (Miscellaneous) and Clinical Neurology, the journal is dedicated to fostering interdisciplinary dialogue among researchers, clinicians, and students alike. With a focus on innovative findings and clinical advancements, BRAIN serves as a vital resource for those seeking to deepen their understanding of neurological disorders and the evolving landscape of medical research.
Journal of Clinical Neurology
Leading the Charge in Neurological InnovationThe Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.
Applied Neuropsychology-Adult
Connecting research and practice in neuropsychology.Applied Neuropsychology-Adult is a premier journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to advancing the field of neuropsychology with a particular focus on adult populations. Since its inception in 2012, this journal has been a vital platform for disseminating innovative research, reviews, and clinical insights into the cognitive and psychological processes that influence adult behavior and functioning. With an impressive Scopus ranking, including Q3 status in both Developmental and Educational Psychology and Neuropsychology and Physiological Psychology, it demonstrates a commitment to high-quality scholarship that informs both clinical practice and theoretical understanding. Researchers, clinicians, and students alike will benefit from the journal's commitment to open access, providing broad access to valuable knowledge in the domain of neuropsychology. As it converges towards its 2024 milestone, Applied Neuropsychology-Adult continues to be an essential resource for those seeking to deepen their understanding of neuropsychological processes and their application in real-world settings.
Alzheimers & Dementia-Translational Research & Clinical Interventions
Connecting Researchers and Clinicians for a Brighter FutureAlzheimer's & Dementia: Translational Research & Clinical Interventions, published by WILEY, is a premier open-access journal that has been at the forefront of innovations in the field of neurology and psychiatry since its inception in 2015. With an impressive impact factor reflecting its high-quality research contributions, this journal has been designated as Q1 in both Neurology (Clinical) and Psychiatry and Mental Health categories for 2023, ranking in the top percentiles of their respective Scopus fields. The journal aims to bridge the gap between research and clinical practice, promoting the translation of scientific discoveries into real-world applications for Alzheimer's disease and other dementias. Positioned in the United States, it is a valuable resource for researchers, clinicians, and students dedicated to advancing knowledge and treatment approaches in these critical areas. With its commitment to open access, the journal ensures that vital research is accessible to a broad audience, fostering collaboration and knowledge sharing across the global scientific community.
Cognitive and Behavioral Neurology
Elevating Knowledge in Cognitive and Behavioral NeurologyCognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.
Cognitive Neuropsychiatry
Shaping Perspectives: Pioneering Research in Cognitive NeuropsychiatryCognitive Neuropsychiatry is a distinguished academic journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to the intersection of cognitive neuroscience and psychiatry. With a strong commitment to advancing knowledge in these rapidly evolving fields, this journal provides a platform for high-quality, peer-reviewed research that explores cognitive processes underlying psychiatric disorders. Aiming to bridge gaps between neuroscience and clinical practice, it serves as an essential resource for researchers, professionals, and students alike. As evidenced by its performance metrics, the journal ranks in the Q2 quartile for Psychiatry and Mental Health, and Q3 for Cognitive Neuroscience, showcasing its relevance and growing impact, particularly among a competitive audience. While it does not currently offer open access options, Cognitive Neuropsychiatry remains a vital outlet for disseminating impactful findings, offering insights that shape contemporary psychiatric understanding and interventions.
Journal of Alzheimers Disease Reports
Advancing Knowledge in Alzheimer's ResearchJournal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.